CD8A and endometrial cancer: However, a recent study showed a significantly higher density of infiltrating immune cell effectors in LS-associated endometrial cancers compared to sporadic MMR-deficient endometrial cancers, with more CD8+, CD45RO+, and PD1+ T-cells at the invasive margin [51].